Bottom line
What does HTEC hold?
HTEC held 63 positions as of Jul 31, 2026. Its largest holding is Caredx, Inc. at 2.68% of the fund, and the top 10 positions add up to 22.1%. By asset type it is 100% stocks, 0% cash & short-term funds.
Updated Sep 28, 2026
HTEC top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | Caredx, Inc. CAREDX INC COMMON STOCK |
Stocks | 2.68% | $1.9M |
| 2 | Guardant Health, Inc. GUARDANT HEALTH INC COMMON STOCK |
Stocks | 2.31% | $1.6M |
| 3 | Natera, Inc. NATERA INC COMMON STOCK |
Stocks | 2.23% | $1.5M |
| 4 | Twist Bioscience Corp TWIST BIOSCIENCE CORP COMMON STOCK |
Stocks | 2.23% | $1.5M |
| 5 | Thermo Fisher Scientific Incorporated THERMO FISHER SCIENTIFIC INC COMMON STOCK |
Stocks | 2.18% | $1.5M |
| 6 | Medpace Holdings, Inc. MEDPACE HOLDINGS INC COMMON STOCK |
Stocks | 2.12% | $1.5M |
| 7 | Adaptive Biotechnologies Corporation ADAPTIVE BIOTECHNOLOGIES COMMON STOCK |
Stocks | 2.11% | $1.5M |
| 8 | Iqvia Holdings Inc IQVIA HOLDINGS INC COMMON STOCK |
Stocks | 2.10% | $1.5M |
| 9 | Illumina, Inc. ILLUMINA INC COMMON STOCK |
Stocks | 2.09% | $1.4M |
| 10 | Arrowhead Pharmaceuticals, Inc. ARROWHEAD PHARMACEUTICALS IN COMMON STOCK |
Stocks | 2.08% | $1.4M |
| 11 | Regeneron Pharmaceuticals, Inc. REGENERON PHARMACEUTICALS COMMON STOCK |
Stocks | 1.97% | $1.4M |
| 12 | Glaukos Corporation GLAUKOS CORP COMMON STOCK |
Stocks | 1.92% | $1.3M |
| 13 | Vertex Pharmaceuticals Incorporated VERTEX PHARMACEUTICALS INC COMMON STOCK |
Stocks | 1.91% | $1.3M |
| 14 | Stryker Corporation STRYKER CORP COMMON STOCK |
Stocks | 1.91% | $1.3M |
| 15 | Livanova Plc LIVANOVA PLC COMMON STOCK |
Stocks | 1.87% | $1.3M |
| 16 | Siemens Healthineers AG SIEMENS HEALTHINEERS AG COMMON STOCK |
Stocks | 1.85% | $1.3M |
| 17 | Lonza Group AG LONZA GROUP AG-REG COMMON STOCK |
Stocks | 1.85% | $1.3M |
| 18 | Incyte Corporation INCYTE CORP COMMON STOCK |
Stocks | 1.80% | $1.2M |
| 19 | Abbott Laboratories ABBOTT LABORATORIES COMMON STOCK |
Stocks | 1.79% | $1.2M |
| 20 | AxoGen, Inc. AXOGEN INC COMMON STOCK |
Stocks | 1.77% | $1.2M |
| 21 | Boston Scientific Corporation BOSTON SCIENTIFIC CORP COMMON STOCK |
Stocks | 1.73% | $1.2M |
| 22 | Grail Inc GRAIL INC COMMON STOCK |
Stocks | 1.72% | $1.2M |
| 23 | Charles River Laboratories International, Inc. CHARLES RIVER LABORATORIES COMMON STOCK |
Stocks | 1.71% | $1.2M |
| 24 | Danaher Corporation DANAHER CORP COMMON STOCK |
Stocks | 1.67% | $1.2M |
| 25 | Tecan Group AG TECAN GROUP AG-REG COMMON STOCK |
Stocks | 1.66% | $1.1M |
Source: SEC Form N-PORT, period ended Jul 31, 2026, filed Sep 28, 2026